Knockdown of lnc-COL6A1-6 mitigated VIC calcification by attenuating autophagic activity, positioning it as a promising therapeutic target for CAVD. Here, COL6A1 is linked to congenital bilateral aplasia of vas deferens from CFTR mutation.